Do you or a loved one live with Resistant Hypertension (HRT) or High Blood Pressure (HBP)?

You may be eligible to participate in this study.

Do you or a loved one live with Resistant Hypertension (HRT) or High Blood Pressure (HBP)? You may be eligible to participate in this study.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Resistant Hypertension (RHT) Clinical Trial in Charlotte NC
NCT03541174 | Phase 3 | Interventional

What you may receive

Compensation of $80 per performed visit will be paid to you for time spent EXCEPT for visits 4, 6, 11 and 13 which will be $160.

Study related procedures

Travel expenses covered

No insurance needed

Do you or a loved one live with Resistant Hypertension (HRT) or High Blood Pressure (HBP)?

You may be eligible to participate in this study.

Do you or a loved one live with Resistant Hypertension (HRT) or High Blood Pressure (HBP)? You may be eligible to participate in this study.

Completed

Male & Female

18 Years +

This study has recruited 730 Participants

Resistant hypertension is defined as hypertension that is poorly responsive to treatment and requires the use of multiple medications to achieve acceptable blood pressure ranges. This study compares the effect of Aprocitentan, a new drug, against existing treatment in lowering blood pressure for individuals who have resistant hypertension.

Why should I participate?

You will receive study related treatment at no cost, as well as compensation for your time and travel. The results of this clinical trial could lead to new treatments that will help treat individuals impacted by RHT.

What's involved?

After a patient applies to the study, they will be contacted to schedule an appointment for their screening visit. The first screening visit will take place between 4 to 12 weeks from the time of application. During the treatment period, there will be 12 study visits over approximately 1 year.

Who can participate?

If you are 18 years or older, experiencing difficult to control blood pressure, and are being treated with three different blood pressure medications you may qualify for this study.